Orion Pharma Limited (DSE:ORIONPHARM)

Market Cap	6.69B
Revenue (ttm)	3.23B
Net Income (ttm)	-540.39M
Shares Out	234.00M
EPS (ttm)	-2.31
PE Ratio	n/a
Forward PE	n/a
Dividend	1.00 (3.57%)
Ex-Dividend Date	Dec 5, 2024

Volume	294,528
Average Volume	263,163
Open	28.40
Previous Close	28.00
Day's Range	28.20 - 29.10
52-Week Range	22.90 - 42.90
Beta	-0.58
RSI	46.39
Earnings Date	Nov 11, 2025

About Orion Pharma

Orion Pharma Limited engages in the creation, discovery, development, manufacturing, and marketing of pharmaceutical products in Bangladesh. It produces products in various dosage forms, including tablets, capsules, syrups, suspensions, injections, and dry powder for syrup/ suspension in various therapeutic groups, such as anticancer, antibiotics, anti-diabetics, anxiolytics, diuretics, cardiovascular drugs, etc. The company also provides various vaccines and health-related consumer products, as well as generates and supplies electricity. The c...

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Employees: 2,954
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ORIONPHARM